Catalyst Event
Akeso Inc (9926) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
4/28/2026, 12:00:00 AM
Ivonescimab (PD-1/VEGF bispecific antibody) received multiple upgraded Class I recommendations in the 2026 Chinese Society of Clinical Oncology (CSCO) guidelines for Non-Small Cell Lung Cancer (NSCLC), strengthening its position as a preferred first-line treatment. Estimated price impact ≥10% due to major clinical guideline upgrade. Expected.
Korean Translation
이보네시맙(PD-1/VEGF 이중항체), 2026년 중국임상종양학회(CSCO) 비소세포폐암(NSCLC) 가이드라인에서 1차 수준의 1등급 상향 추찜을 받음. 주요 임상 가이드라인 상향으로 10% 이상의 주가 영향이 예상됨.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
Honeywell International Inc (HON) · Trading Issue
Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.
6/29/2026, 12:00:00 AM
BYD Electronic International Co Ltd (285) · Other
Ex-dividend date (2026-06-11) for the final dividend of RMB 0.156 per share for the year ended December 31, 2025, scheduled. Low importance as dividend distributions typically result in price adjustments of ~1%.
6/11/2026, 12:00:00 AM
Honeywell International Inc (HON) · Other
A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.
6/5/2026, 12:00:00 AM
Time Interconnect Technology Ltd (1729) · Other
Annual General Meeting on 2026-05-29 to approve FY2025 results, a final dividend of HK2.4 cents per share, and a mandate to issue up to 20% new shares scheduled.
5/29/2026, 12:00:00 AM
SALESFORCE INC (CRM) · Earnings Release
Salesforce is scheduled to release its Q1 FY2027 earnings results on May 27, 2026, after market close. Importance is estimated as Low based on historical price stability during similar announcements, scheduled.
5/27/2026, 12:00:00 AM